These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 31315356)

  • 1. [Feasibility analysis of pepsin strip test in diagnosis of laryngopharyngeal reflux disease].
    Wang JS; Li JR; Wu MK
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Jul; 54(7):501-505. PubMed ID: 31315356
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative study on 24-hour multichannel intraluminal impedance-pH monitoring and Dx-pH monitoring in the diagnosis of laryngopharyngeal reflux].
    Wang JS; Li JR
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Apr; 53(4):270-275. PubMed ID: 29747251
    [No Abstract]   [Full Text] [Related]  

  • 3. Saliva pepsin level of laryngopharyngeal reflux patients is not correlated with reflux episodes.
    Bobin F; Journe F; Lechien JR
    Laryngoscope; 2020 May; 130(5):1278-1281. PubMed ID: 31461170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal timing of saliva collection to detect pepsin in patients with laryngopharyngeal reflux.
    Na SY; Kwon OE; Lee YC; Eun YG
    Laryngoscope; 2016 Dec; 126(12):2770-2773. PubMed ID: 27075393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Pepsin and Oropharyngeal pH-Monitoring to Assess the Postoperative Outcome of Patients with Laryngopharyngeal Reflux: Results of a Pilot Trial.
    Weitzendorfer M; Pfandner R; Antoniou SA; Langsteger W; Witzel K; Emmanuel K; Koch OO
    J Laparoendosc Adv Surg Tech A; 2017 Sep; 27(9):937-943. PubMed ID: 28731842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of salivary and nasal lavage pepsin with MII-pH testing.
    Klimara MJ; Johnston N; Samuels TL; Visotcky AM; Poetker DM; Loehrl TA; Blumin JH; Bock JM
    Laryngoscope; 2020 Apr; 130(4):961-966. PubMed ID: 31329290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypopharyngeal-Esophageal Impedance-pH Monitoring Profiles of Laryngopharyngeal Reflux Patients.
    Lechien JR; Bobin F; Dapri G; Eisendrath P; Salem C; Mouawad F; Horoi M; Thill MP; Dequanter D; Rodriguez A; Muls V; Saussez S
    Laryngoscope; 2021 Feb; 131(2):268-276. PubMed ID: 32438465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of Peptest™ in Patients with Gastro-Esophageal Reflux Disease and Laryngopharyngeal Reflux Undergoing Impedance Testing.
    Bor S; Capanoglu D; Vardar R; Woodcock AD; Fisher J; Dettmar PW
    J Gastrointestin Liver Dis; 2019 Dec; 28(4):383-387. PubMed ID: 31826051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic Utility of Salivary Pepsin as Compared With 24-Hour Dual pH/Impedance Probe in Laryngopharyngeal Reflux.
    Zhang M; Chia C; Stanley C; Phyland DJ; Paddle PM
    Otolaryngol Head Neck Surg; 2021 Feb; 164(2):375-380. PubMed ID: 32895009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Application of 24-hour multichannel intraluminal impedance in combination with pH monitoring for the diagnosis of laryngopharyngeal reflux: a pilot study].
    Wang J; Li J; Li X; Ma N
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Jul; 50(7):564-8. PubMed ID: 26695979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnostic value of pepsin concentration in saliva for laryngopharyngeal reflux disease.
    Yu L; Li R; Du L; Zhao Y
    Eur Arch Otorhinolaryngol; 2022 Dec; 279(12):5783-5789. PubMed ID: 35689682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is the pepsin immunohistochemical staining of laryngeal lesions an available way for diagnosing laryngopharyngeal reflux.
    Wang J; Li J; Li X; Zhang S
    Acta Otolaryngol; 2020 Aug; 140(8):702-705. PubMed ID: 32400239
    [No Abstract]   [Full Text] [Related]  

  • 13. Pepsin and oropharyngeal pH monitoring to diagnose patients with laryngopharyngeal reflux.
    Weitzendorfer M; Antoniou SA; Schredl P; Witzel K; Weitzendorfer IC; Majerus A; Emmanuel K; Koch OO
    Laryngoscope; 2020 Jul; 130(7):1780-1786. PubMed ID: 31603541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between Pepsin in the Saliva and the Subjective Symptoms in Patients With Laryngopharyngeal Reflux.
    Jung AR; Kwon OE; Park JM; Dong SH; Jung SY; Lee YC; Eun YG
    J Voice; 2019 Mar; 33(2):150-154. PubMed ID: 29174850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between 24-hour combined multichannel intraluminal impedance-pH monitoring and symptoms or quality of life in patients with laryngopharyngeal reflux.
    Kim SI; Kwon OE; Na SY; Lee YC; Park JM; Eun YG
    Clin Otolaryngol; 2017 Jun; 42(3):584-591. PubMed ID: 28004504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of pepsin in tears of children with laryngopharyngeal reflux disease.
    Iannella G; Di Nardo G; Plateroti R; Rossi P; Plateroti AM; Mariani P; Magliulo G
    Int J Pediatr Otorhinolaryngol; 2015 Dec; 79(12):2312-5. PubMed ID: 26586244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are Multiple Tests Necessary for Salivary Pepsin Detection in the Diagnosis of Laryngopharyngeal Reflux?
    Wang J; Li J; Nie Q; Zhang R
    Otolaryngol Head Neck Surg; 2022 Mar; 166(3):477-481. PubMed ID: 34253110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual pH with Multichannel Intraluminal Impedance Testing in the Evaluation of Subjective Laryngopharyngeal Reflux Symptoms.
    Cumpston EC; Blumin JH; Bock JM
    Otolaryngol Head Neck Surg; 2016 Dec; 155(6):1014-1020. PubMed ID: 27554506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of combined 24-hour multichannel intraluminal impedance-pH monitoring in the evaluation of children with suspected laryngopharyngeal reflux.
    Pavić I; Babić I; Čepin Bogović J; Hojsak I
    Clin Otolaryngol; 2017 Jun; 42(3):544-549. PubMed ID: 27727523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical utility of salivary pepsin measurement in patients with proton pump inhibitor-refractory gastroesophageal reflux disease symptoms: a prospective comparative study.
    Matsumura T; Arai M; Suzuki T; Hoppo T; Seki Y; Kasamatsu S; Ishigami H; Ishikawa K; Okimoto K; Akizue N; Maruoka D; Nakagawa T; Odaka T; Okamoto Y; Kato N
    Esophagus; 2020 Jul; 17(3):339-347. PubMed ID: 31982992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.